These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 7606733

  • 1. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck.
    Liu TJ, el-Naggar AK, McDonnell TJ, Steck KD, Wang M, Taylor DL, Clayman GL.
    Cancer Res; 1995 Jul 15; 55(14):3117-22. PubMed ID: 7606733
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis induction by E2F-1 via adenoviral-mediated gene transfer results in growth suppression of head and neck squamous cell carcinoma cell lines.
    Liu TJ, Wang M, Breau RL, Henderson Y, El-Naggar AK, Steck KD, Sicard MW, Clayman GL.
    Cancer Gene Ther; 1999 Jul 15; 6(2):163-71. PubMed ID: 10195883
    [Abstract] [Full Text] [Related]

  • 3. In vivo molecular therapy with p53 adenovirus for microscopic residual head and neck squamous carcinoma.
    Clayman GL, el-Naggar AK, Roth JA, Zhang WW, Goepfert H, Taylor DL, Liu TJ.
    Cancer Res; 1995 Jan 01; 55(1):1-6. PubMed ID: 7805018
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bystander effect in the adenovirus-mediated wild-type p53 gene therapy model of human squamous cell carcinoma of the head and neck.
    Frank DK, Frederick MJ, Liu TJ, Clayman GL.
    Clin Cancer Res; 1998 Oct 01; 4(10):2521-8. PubMed ID: 9796986
    [Abstract] [Full Text] [Related]

  • 6. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer.
    Hamada K, Alemany R, Zhang WW, Hittelman WN, Lotan R, Roth JA, Mitchell MF.
    Cancer Res; 1996 Jul 01; 56(13):3047-54. PubMed ID: 8674061
    [Abstract] [Full Text] [Related]

  • 7. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK, Liu TJ, Frederick MJ, Clayman GL.
    Clin Cancer Res; 1998 Sep 01; 4(9):2265-72. PubMed ID: 9748148
    [Abstract] [Full Text] [Related]

  • 8. Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trials.
    Overholt SM, Liu TJ, Taylor DL, Wang M, El-Naggar AK, Shillitoe E, Adler-Storthz K, John LS, Zhang WW, Roth JA, Clayman GL.
    Clin Cancer Res; 1997 Feb 01; 3(2):185-91. PubMed ID: 9815671
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of apoptosis-related genes in human head and neck squamous cell carcinomas undergoing p53-mediated programmed cell death.
    Frederick MJ, Holton PR, Hudson M, Wang M, Clayman GL.
    Clin Cancer Res; 1999 Feb 01; 5(2):361-9. PubMed ID: 10037186
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model.
    Eicher SA, Clayman GL, Liu TJ, Shillitoe EJ, Storthz KA, Roth JA, Lotan R.
    Clin Cancer Res; 1996 Oct 01; 2(10):1659-64. PubMed ID: 9816113
    [Abstract] [Full Text] [Related]

  • 12. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.
    Ji L, Fang B, Yen N, Fong K, Minna JD, Roth JA.
    Cancer Res; 1999 Jul 15; 59(14):3333-9. PubMed ID: 10416589
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A preclinical model of minimal residual cancer in the muscle highlights challenges associated with adenovirus-mediated p53 gene transfer.
    Oakley R, Phillips E, Hooper R, Wilson D, Partridge M.
    Clin Cancer Res; 2002 Jun 15; 8(6):1984-94. PubMed ID: 12060644
    [Abstract] [Full Text] [Related]

  • 15. Adenoviral p53 gene therapy in head and neck squamous cell carcinoma cell lines.
    Higuchi Y, Asaumi J, Murakami J, Wakasa T, Inoue T, Kuroda M, Shibuya K, Shigehara H, Kawasaki S, Fukui K, Kishi K, Hiraki Y.
    Oncol Rep; 2002 Jun 15; 9(6):1233-6. PubMed ID: 12375026
    [Abstract] [Full Text] [Related]

  • 16. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL, Sinha UK.
    Head Neck; 2006 Jan 15; 28(1):15-23. PubMed ID: 16302195
    [Abstract] [Full Text] [Related]

  • 17. p53-dependent G2 arrest associated with a decrease in cyclins A2 and B1 levels in a human carcinoma cell line.
    Badie C, Bourhis J, Sobczak-Thépot J, Haddada H, Chiron M, Janicot M, Janot F, Tursz T, Vassal G.
    Br J Cancer; 2000 Feb 15; 82(3):642-50. PubMed ID: 10682678
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation.
    Spitz FR, Nguyen D, Skibber JM, Meyn RE, Cristiano RJ, Roth JA.
    Clin Cancer Res; 1996 Oct 15; 2(10):1665-71. PubMed ID: 9816114
    [Abstract] [Full Text] [Related]

  • 20. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
    Wang Q, Han D, Wang W.
    Zhonghua Zhong Liu Za Zhi; 1998 Nov 15; 20(6):418-21. PubMed ID: 10920932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.